Analysts Set U.S. Physical Therapy, Inc. (NYSE:USPH) PT at $114.00

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have received an average recommendation of “Buy” from the five brokerages that are presently covering the firm, Marketbeat reports. Four analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $114.00.

Several equities research analysts have commented on the stock. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price objective for the company from $100.00 to $115.00 in a report on Monday, December 16th. JMP Securities started coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price target on the stock. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Barrington Research reissued an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Finally, JPMorgan Chase & Co. increased their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd.

Insider Activity at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the sale, the chief financial officer now directly owns 20,469 shares of the company’s stock, valued at $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of institutional investors and hedge funds have recently bought and sold shares of USPH. Bahl & Gaynor Inc. raised its stake in U.S. Physical Therapy by 135.4% in the fourth quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company’s stock valued at $23,076,000 after purchasing an additional 149,622 shares in the last quarter. State Street Corp grew its position in U.S. Physical Therapy by 17.5% during the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after acquiring an additional 99,244 shares during the last quarter. Copeland Capital Management LLC grew its position in U.S. Physical Therapy by 9.5% during the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after acquiring an additional 72,715 shares during the last quarter. Raymond James Financial Inc. bought a new position in U.S. Physical Therapy during the fourth quarter valued at approximately $6,240,000. Finally, Southernsun Asset Management LLC grew its position in U.S. Physical Therapy by 10.5% during the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after acquiring an additional 52,062 shares during the last quarter.

U.S. Physical Therapy Price Performance

NYSE USPH opened at $85.12 on Thursday. The company has a market cap of $1.29 billion, a PE ratio of 90.55, a price-to-earnings-growth ratio of 3.61 and a beta of 1.48. U.S. Physical Therapy has a 52 week low of $76.18 and a 52 week high of $113.63. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm’s 50-day simple moving average is $90.29 and its two-hundred day simple moving average is $88.17.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.